Marshall Wace North America’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $551M | Sell |
963,909
-49,797
| -5% | -$28.5M | 2.35% | 6 |
|
|
2021
Q2 | $511M | Buy |
1,013,706
+286,186
| +39% | +$144M | 2.13% | 6 |
|
|
2021
Q1 | $332M | Sell |
727,520
-83,070
| -10% | -$37.9M | 1.37% | 8 |
|
|
2020
Q4 | $378M | Buy |
810,590
+509,875
| +170% | +$237M | 1.7% | 6 |
|
|
2020
Q3 | $133M | Sell |
300,715
-67,957
| -18% | -$30M | 0.85% | 22 |
|
|
2020
Q2 | $134M | Sell |
368,672
-111,700
| -23% | -$40.5M | 0.88% | 21 |
|
|
2020
Q1 | $136M | Sell |
480,372
-285,987
| -37% | -$81.1M | 1.03% | 15 |
|
|
2019
Q4 | $249M | Buy |
766,359
+40,811
| +6% | +$13.3M | 1.2% | 15 |
|
|
2019
Q3 | $211M | Buy |
725,548
+250,602
| +53% | +$73M | 1.2% | 13 |
|
|
2019
Q2 | $139M | Buy |
474,946
+166,927
| +54% | +$49M | 0.87% | 27 |
|
|
2019
Q1 | $84.3M | Buy |
308,019
+294,820
| +2,234% | +$80.7M | 0.6% | 46 |
|
|
2018
Q4 | $2.95M | Buy |
+13,199
| New | +$2.95M | 0.03% | 355 |
|
|
2017
Q2 | – | Sell |
-231,025
| Closed | -$35.6M | – | 1460 |
|
|
2017
Q1 | $35.6M | Buy |
+231,025
| New | +$35.6M | 0.28% | 101 |
|
|
2013
Q4 | – | Sell |
-208,206
| Closed | -$19.2M | – | 837 |
|
|
2013
Q3 | $19.2M | Buy |
208,206
+97,051
| +87% | +$8.94M | 0.59% | 39 |
|
|
2013
Q2 | $9.41M | Buy |
+111,155
| New | +$9.41M | 0.74% | 38 |
|